James Shepherd
Overview
Explore the profile of James Shepherd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
9967
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Welsh P, Polisecki E, Robertson M, Jahn S, Buckley B, de Craen A, et al.
Endocr Rev
. 2017 Feb;
30(7):927-928.
PMID: 28199503
No abstract available.
12.
Kunkel A, Crawford F, Shepherd J, Cohen T
AIDS
. 2016 Oct;
30(17):2715-2723.
PMID: 27782966
Objective: Extending the duration of isoniazid preventive therapy (IPT) among people living with HIV (PLHIV) may improve its effectiveness at both individual and population levels, but could also increase selective...
13.
Auld A, Agizew T, Pals S, Finlay A, Ndwapi N, Boyd R, et al.
BMC Infect Dis
. 2016 Oct;
16(1):606.
PMID: 27782821
Background: In 2012, as a pilot for Botswana's national Xpert MTB/RIF (Xpert) rollout plans, intensified tuberculosis (TB) case finding (ICF) activities were strengthened at 22 HIV treatment clinics prior to...
14.
Shepherd J, Breazna A, Deedwania P, LaRosa J, Wenger N, Messig M, et al.
Am J Cardiol
. 2016 Mar;
117(8):1199-205.
PMID: 26940556
Statins may have nephroprotective as well as cardioprotective effects in patients with cardiovascular disease. In the Treating to New Targets (TNT) study (NCT00327691), patients with coronary heart disease (CHD) were...
15.
Samandari T, Agizew T, Nyirenda S, Tedla Z, Sibanda T, Mosimaneotsile B, et al.
AIDS
. 2015 Feb;
29(3):351-9.
PMID: 25686683
Objective: Thirty-six months of isoniazid preventive therapy (36IPT) was superior to 6 months of IPT (6IPT) in preventing tuberculosis (TB) among HIV-infected adults in Botswana. We assessed the posttrial durability...
16.
Arsenault B, Barter P, DeMicco D, Bao W, Preston G, LaRosa J, et al.
PLoS One
. 2014 Dec;
9(12):e114519.
PMID: 25531109
Unlabelled: Several plasma non-lipid biomarkers have been shown to predict major cardiovascular events (MCVEs) in population studies. Our objective was to investigate the relationship between lipid and non-lipid biomarkers levels...
17.
Jindani A, Harrison T, Nunn A, Phillips P, Churchyard G, Charalambous S, et al.
N Engl J Med
. 2014 Oct;
371(17):1599-608.
PMID: 25337749
Background: Tuberculosis regimens that are shorter and simpler than the current 6-month daily regimen are needed. Methods: We randomly assigned patients with newly diagnosed, smear-positive, drug-sensitive tuberculosis to one of...
18.
Etiebet M, Shepherd J, Nowak R, Charurat M, Chang H, Ajayi S, et al.
AIDS
. 2012 Oct;
27(4):553-61.
PMID: 23079810
Background: In resource-limited settings, HIV-1 drug resistance testing to guide antiretroviral therapy (ART) selection is unavailable. We retrospectively conducted genotypic analysis on archived samples from Nigerian patients who received targeted...
19.
Kaye J, Curren L, Anderson N, Edwards K, Fullerton S, Kanellopoulou N, et al.
Nat Rev Genet
. 2012 Apr;
13(5):371-6.
PMID: 22473380
Advances in computing technology and bioinformatics mean that medical research is increasingly characterized by large international consortia of researchers that are reliant on large data sets and biobanks. These trends...
20.
Stein E, Vidt D, Shepherd J, Cain V, Anzalone D, Cressman M
Atherosclerosis
. 2012 Feb;
221(2):471-7.
PMID: 22304793
Objective: Intensive lowering of low-density lipoprotein cholesterol (LDL-C) with statins reduces cardiovascular risk but can cause liver-, muscle-, and possibly renal-related adverse events (AEs). We assessed the effects of rosuvastatin...